Pharmaceutical

Filter

Current filters:

None

Popular Filters

130 to 154 of 7209 results

Australia needs targeted reform to reflect global regulatory environment: Medicines Australia chief

Australia needs targeted reform to reflect global regulatory environment: Medicines Australia chief

12-01-2015

Australian pharma representative body Medicines Australia has put forward its recommendations for consideration…

AustraliaMedicines AustraliaPharmaceuticalRegulationTechnology

Bristol-Myers stops Opdivo NSCLC study early on good results

12-01-2015

US pharma major Bristol-Myers Squibb says that an open-label, randomized Phase III study evaluating Opdivo…

Bristol-Myers SquibbOncologyOpdivoPharmaceuticalResearch

US insurance firm Anthem chooses Gilead’s Harvoni as primary HCV drug

US insurance firm Anthem chooses Gilead’s Harvoni as primary HCV drug

12-01-2015

US biotech major Gilead Sciences has signed an agreement with US health insurance firm Anthem to provide…

Anti-viralsGileadHarvoniPharmaceuticalPricingUSA

AbbVie issues earnings-per-share guidance up 30% for 2015

AbbVie issues earnings-per-share guidance up 30% for 2015

12-01-2015

US drugmaker AbbVie has issued updated guidance about its expected earnings in 2015.

AbbVieAnti-viralsFinancialHumiraPharmaceuticalUSAViekira Pak

US Senators reintroduce bill to allow cheaper drug imports from Canada

12-01-2015

US Senators Amy Klobuchar (Democrat, Minnesota) and John McCain (Republican, Arizona) last week resumed…

CanadaLegalPharmaceuticalPoliticsUSA

Esteve could earn $1 billion from pain partnership with Mundipharma and Purdue

Esteve could earn $1 billion from pain partnership with Mundipharma and Purdue

12-01-2015

Swiss drugmaker Mundipharma Laboratories and its independent associated company, Purdue Pharmaceuticals,…

E-52862E-58425Esteve GroupLicensingMundipharmaNeurologicalPharmaceuticalPurdue PharmaResearch

KaloBios president and chief executive David Pritchard retires

KaloBios president and chief executive David Pritchard retires

11-01-2015

KaloBios Pharmaceuticals has announced its president and chief executive, David Pritchard, is to retire.

BoardroomBusiness FinanceKaloBios PharmaceuticalsPharmaceuticalPresident and chief executiveUSA

EMA backs record number of drugs for rare diseases in 2014

EMA backs record number of drugs for rare diseases in 2014

11-01-2015

The European Medicines Agency recommended the highest number of orphan designated medicines for marketing…

CyramzaEuropeGazyvaroHoloclarImbruvicaMekinistPharmaceuticalRegulationScenesseTranslarna

Daiichi Sankyo agees to pay $39 million to settle US kickback allegations

Daiichi Sankyo agees to pay $39 million to settle US kickback allegations

11-01-2015

The US subsidiary of Japanese drug major Daiichi Sankyo has agreed to pay the United States and state…

Daiichi SankyoFinancialMarkets & MarketingPharmaceuticalUSA

Portola announces positive Phase II results of andexanet alfa with Xarelto

Portola announces positive Phase II results of andexanet alfa with Xarelto

09-01-2015

Portola Pharmaceuticals has announced positive results from the first part of Phase III trial of andexanet…

andexanet alfaBayerHematologyPharmaceuticalPortola PharmaceuticalsResearchUSAXarelto

AMRI to acquire Aptuit businesses units for $60 million

AMRI to acquire Aptuit businesses units for $60 million

09-01-2015

US-based drug development and discovery company Aptuit has divested its aseptic clinical manufacturing…

Albany Molecular ResearchAptuitMergers & AcquisitionsPharmaceuticalProductionUSA

Standardization of European HTA bodies is inevitable: EFPIA head

Standardization of European HTA bodies is inevitable: EFPIA head

09-01-2015

The director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA)…

EFPIAEuropeMarkets & MarketingPharmaceuticalPricingRegulation

FDA sees no need for advisory panel meeting over Pfizer’s Ibrance

09-01-2015

US pharma giant Pfizer says it has been advised by the Food and Drug Administration that at this time…

IbranceOncologypalbociclibPfizerPharmaceuticalRegulationUSA

GW and Otsuka report Sativex failed to meet primary endpoint in cancer pain

GW and Otsuka report Sativex failed to meet primary endpoint in cancer pain

09-01-2015

UK-based GW Pharmaceuticals and Japanese drugmaker Otsuka have reported that Sativex (nabiximols) did…

AnalgesiaGW PharmaceuticalsOncologyOtsuka PharmaceuticalPharmaceuticalResearchSativexUKUSA

Favorable investment climate and health care reforms will fuel Turkey’s life sciences industry; report

09-01-2015

Big pharmaceutical companies and foreign investors are flocking to Turkey to capitalize on its encouraging…

Markets & MarketingPharmaceuticalPricingRegulationTurkey

FDA approves Daiichi Sankyo’s anti-clotting drug Savaysa

09-01-2015

The US Food and Drug Administration late yesterday approved Japanese drug major Daiichi Sankyo’s anti-clotting…

Cardio-vascularDaiichi SankyoedoxabanPharmaceuticalRegulationSavaysaUSA

FDA Focus: Recalling dangerous and defective drugs

FDA Focus: Recalling dangerous and defective drugs

08-01-2015

In a monthly FDA-focused blog published exclusively by The Pharma Letter, Dr Nicola Davies looks at how…

DrugsPharmaceuticalRegulationUnited StatesUSA

ViiV’s Triumeq offers added benefit for treatment-naive adults with HIV, says IQWiG

ViiV’s Triumeq offers added benefit for treatment-naive adults with HIV, says IQWiG

08-01-2015

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG), which had already assessed a…

Anti-viralsGermanyGlaxoSmithKlinePharmaceuticalPricingRegulationTriumeqViiV Healthcare

Ph III trial for AbbVie’s elagolix meets endpoints

08-01-2015

US pharma major AbbVie and partner Neurocrine Biosciences have announced positive top-line results from…

AbbVieelagolixNeurocrine BiosciencesPharmaceuticalResearchWomen's Health

130 to 154 of 7209 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top